Abstract:Protein expression systems are widely used in biotechnology and medicine for the efficient and economic production of therapeutic proteins. Today, cultivated Chinese hamster ovary (CHO) cells are the market dominating mammalian cell-line for the production of complex therapeutic proteins. Despite this outstanding potential of CHO cells, no high-yield cell-free system based on translationally active lysates from these cells has been reported so far. To date, CHO cell extracts have only been used as a foundational research tool for understanding mRNA translation (Lodish et al., 1974; McDowell et al., 1972). In the present study, we address this fact by establishing a novel cell-free protein expression system based on extracts from cultured CHO cells. Lysate preparation, adaptation of in vitro reaction conditions and the construction of particular expression vectors are considered for high-yield protein production. A specific in vitro expression vector, which includes an internal ribosome entry site (IRES) from the intergenic region (IGR) of the Cricket paralysis virus (CrPV), has been constructed in order to obtain optimal performance. The IGR IRES is supposed to bind directly to the eukaryotic 40S ribosomal subunit thereby bypassing the process of translation initiation, which is often a major bottleneck in cell-free systems. The combination of expression vector and optimized CHO cell extracts enables the production of approximately 50 µg/mL active firefly luciferase within 4 h. The batch-type cell-free coupled transcription-translation system has the potential to perform post-translational modifications, as shown by the glycosylation of erythropoietin. Accordingly, the system contains translocationally active endogenous microsomes, enabling the co-translational incorporation of membrane proteins into biological membranes. Hence, the presented in vitro translation system is a powerful tool for the fast and convenient optimization of expression constructs, the specific labeling of integral membrane proteins and the cell-free production of posttranslationally modified proteins.

Efficient cell-free translation from diverse human cell types

A highly efficient human cell-free translation system

Cell-Free Protein Synthesis: Pros and Cons of Prokaryotic and Eukaryotic Systems

Construction of an Efficient Escherichia Coli Cell‐free System for in Vitro Expression of Several Kinds of Proteins

Cell‐free protein expression based on extracts from CHO cells

Cell-Free Systems Based on CHO Cell Lysates: Optimization Strategies, Synthesis of “Difficult-to-Express” Proteins and Future Perspectives

Development Of A Robust Escherichia Coli-Based Cell-Free Protein Synthesis Application Platform

Cell-free protein synthesis: Applications come of age

Heterologous and cell free protein expression systems

Methods for Expression of Recombinant Proteins Using a Pichia pastoris Cell‐Free System

Enhancing the Efficiency of Cell-Free Protein Synthesis System by Systematic Titration of Transcription and Translation Components

Cell Engineering and Cultivation of Chinese Hamster Ovary Cells for the Development of Orthogonal Eukaryotic Cell-free Translation Systems

Preparing Protein Producing Synthetic Cells using Cell Free Bacterial Extracts, Liposomes and Emulsion Transfer

Rapid and Scalable Preparation of Bacterial Lysates for Cell-Free Gene Expression

A Cost-Effective Pichia pastoris Cell-Free System Driven by Glycolytic Intermediates Enables the Production of Complex Eukaryotic Proteins

Advanced Establishment of Stable Recombinant Human Suspension Cell Lines Using Genotype-Phenotype Coupling Transposon Vectors

Development of a minimal cell-free translation system for the synthesis of presecretory and integral membrane proteins

Advances in cell-free protein synthesis

Functional Analysis of E. Coli Class II Release Factor RF3 Mutants

Cell-Free Translation Quantification via a Fluorescent Minihelix

Optimizing cell‐free protein expression in CHO: Assessing small molecule mass transfer effects in various reactor configurations